The Human LAG3 / CD4 Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between T-cell surface glycoprotein CD4 and its receptor lymphocyte activation gene 3 protein in the presence of potential inhibitors within 4 hours.
4-8 week development phase.
4-8 week development phase.